Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 7/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 1.00 |
| ▸ | HPGD | P15428 | 6/20 | 1.00 |
| ▸ | TP53 | P04637 | 5/20 | 1.00 |
| ▸ | MAPT | P10636 | 5/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 1.00 |
| ▸ | MEN1 | O00255 | 4/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 4/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 3/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 3/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | TNKS | O95271 | 4/20 | 0.87 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.87 |
| ▸ | MAOB | P27338 | 7/20 | 0.83 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.82 |
| ▸ | TSHR | P16473 | 1/20 | 0.82 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.74 |
| ▸ | NPC1 | O15118 | 4/20 | 0.73 |
| ▸ | RAB9A | P51151 | 4/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30266579 | 1.00 | CYP3A4 (1.00) | CYP3A4KDM4EALDH1A1HPGDTP53 | |
| SCHEMBL30120666 | 0.93 | CYP3A4 (1.00) | CYP3A4KDM4EALDH1A1HPGDTP53 | |
| SCHEMBL534596 | 0.93 | CYP3A4 (1.00) | CYP3A4KDM4EALDH1A1HPGDTP53 | |
| 4,7-Dimethoxyflavone SCHEMBL3470601 | 0.91 | MAOB (1.00) | CYP3A4KDM4EALDH1A1HPGDTP53 | |
| SCHEMBL4650062 | 0.90 | MAPT (1.00) | CYP3A4KDM4EALDH1A1HPGDTP53 | |
| SCHEMBL31675778 | 0.90 | MAPT (1.00) | CYP3A4KDM4EALDH1A1HPGDTP53 | |
| SCHEMBL9663461 | 0.88 | CSNK2A2 (0.87) | CYP3A4KDM4EALDH1A1HPGDTP53 | |
| SCHEMBL31238403 | 0.87 | MAPT (0.92) | CYP3A4KDM4EALDH1A1HPGDTP53 | |
| SCHEMBL4160578 | 0.86 | CSNK2A2 (0.81) | CYP3A4KDM4EALDH1A1HPGDTP53 | |
| SCHEMBL9142214 | 0.86 | MAOB (1.00) | CYP3A4KDM4EALDH1A1HPGDTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6872771-B1 | Tire with rubber containing flavone | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2005-03-29 | — | — | US | claimed |
| US-5141745-A | Gene expression | THE LUBRIZOL CORPORATION (US) | 1992-08-25 | — | — | US | claimed |
| EP-0245931-A2 | Nodulation inducing factors | LUBRIZOL GENETICS INC. (US) | 1987-11-19 | — | — | EP | claimed |
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2026-04-30 | — | — | US | disclosed |
| US-20250263774-A1 | DISCOVERING NEW XENOBIOTIC SUBSTRATES OF AN UDP-GLYCOSYLTRANSFERASE WITH A HIGH-THROUGHPUT METHOD | UNIV NORTH TEXAS (US) | 2025-08-21 | — | — | US | disclosed |
| WO-2024073025-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2024-04-04 | — | — | WO | disclosed |
| EP-4344552-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2024-04-03 | — | — | EP | disclosed |
| WO-2021236578-A1 | CHROMEN-4-ONE DERIVATIVES, SUCH AS E.G. FLAVONES, FOR USE AS CK2 INHIBITORS FOR THE TREATMENT OF NEUROINFLAMMATION | SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2021-11-25 | — | — | WO | disclosed |
| US-20210346385-A1 | TASTE-MASKED DOSAGE FORMS | DEEP OCEAN CAPITAL MANAGEMENT LP | 2021-11-11 | — | — | US | disclosed |
| WO-2020061584-A1 | TASTE-MASKED DOSAGE FORMS | MSB HOLDINGS, INC. (US) | 2020-03-26 | — | — | WO | disclosed |
| EP-2730431-B1 | Rubber composition and tire with rubber containing flavone | GOODYEAR TIRE & RUBBER (US) | 2017-06-28 | — | — | EP | disclosed |
| US-5229113-A | Gene expression, soybeans | LUBRIZOL GENETICS, INC. (US) | 1993-07-20 | — | — | US | disclosed |
| US-5141745-A | Gene expression | THE LUBRIZOL CORPORATION (US) | 1992-08-25 | — | — | US | disclosed |
| US-5141745-A | Gene expression | THE LUBRIZOL CORPORATION (US) | 1992-08-25 | — | — | US | disclosed |
| US-5023180-A | Bradyrhizobium japonicum nodulation regulatory protein and gene | LUBRIZOL GENETICS, INC. (US) | 1991-06-11 | — | — | US | disclosed |
| EP-0245931-A3 | NODULATION INDUCING FACTORS | LUBRIZOL GENETICS INC. (US) | 1989-04-12 | — | — | EP | disclosed |
| EP-0269725-A4 | BRADYRHIZOBIUM JAPONICUM NODULATION REGULATORY PROTEIN AND GENE. | LUBRIZOL GENETICS INC (US) | 1989-01-12 | — | — | EP | disclosed |
| EP-0269725-A1 | BRADYRHIZOBIUM JAPONICUM NODULATION REGULATORY PROTEIN AND GENE | LUBRIZOL GENETICS INC. (US) | 1988-06-08 | — | — | EP | disclosed |
| WO-1987007910-A1 | BRADYRHIZOBIUM JAPONICUM NODULATION REGULATORY PROTEIN AND GENE | LUBRIZOL GENETICS, INC. (US) | 1987-12-30 | — | — | WO | disclosed |
| EP-0245931-A2 | Nodulation inducing factors | LUBRIZOL GENETICS INC. (US) | 1987-11-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | PIGS, TAS2R13, CEL | CYP3A4 3591/4885KDM4E 984/4885ALDH1A1 4390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.